San Francisco, California, June 14, 2017 : The global West Nile Virus (WNV) infection is predicted to experience a rapid growth on account of increasing geriatric population, government policies to offer advanced healthcare, and developing healthcare infrastructure. TMR Research predicts that the global West Nile Virus infection market will grow substantially due to increasing investment in research and development activities across the world. The report is titled “West Nile Virus Infection Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025”.
A rising geriatric race on global level along with pool of race with disease defense system are the vital factors driving the West Nile Virus infection treatment market. West Nile Virus is found in dead birds, ticks, and mosquitos. All these mediums are responsible for the increasing number of people suffering from this infection. West Nile Virus mostly attacks elder people, young age group, and people with HIV and other serious diseases. WNV can also be transmitted through infected animals, their blood, and other tissues. The symptoms of this virus include headache, skin rash, body pain, fever, swollen lymph glands, back pain, eye pain, nausea, sore throat, comatose state, paralysis, fatigue, and convulsions.
The global West Nile Virus infection treatment market is anticipated to witness a substantial growth owing to factors such as increasing count of people with weak immune system and rising geriatric population. However, lack of awareness regarding the infection and unavailability of specialized treatment are hampering the growth of the global WNV market. WNV virus is mostly spread through bird as compared to other sources. All these factors are predicted to increase the number cases of WMV infection across the world.
The global West Nile Virus infection treatment market can be classified into Asia Pacific, the Middle East and Africa, Latin America, North America, and Europe. The WNV infection market is expected to witness tremendous growth rate in all these regions owing to factors such as increasing support from governments for development of healthcare industry and addition in the infectious people with WNV. However, some of the countries in the Middle East and Africa region will show low growth rate on account of lack of healthcare infrastructure, financial disturbance, and lack of regulatory framework.
The study presents a detail overview of the factors affecting the growth of the global West Nile Virus infection treatment market. It also discusses the driving and restraining factors along with opportunities prevailing in the industry.
Some of the market participants are driving the growth the global West Nile Virus infection treatment market include Hemispherx Biophrma Inc., Hawail Biotech Inc., CEL-SCI Corporation, and Kineta Inc. Many leading players are investing on the research and development activities in order to increase their shares in the global market.